R
Raymond Reid
Researcher at Johns Hopkins University
Publications - 95
Citations - 5184
Raymond Reid is an academic researcher from Johns Hopkins University. The author has contributed to research in topics: Population & Pneumococcal conjugate vaccine. The author has an hindex of 42, co-authored 94 publications receiving 4781 citations. Previous affiliations of Raymond Reid include Johns Hopkins University School of Medicine & Ithaca College.
Papers
More filters
Journal ArticleDOI
Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial
Katherine L. O'Brien,Lawrence H. Moulton,Raymond Reid,Robert Weatherholtz,Jane Oski,Laura H Brown,Gaurav Kumar,Alan J. Parkinson,Diana Hu,Jill G. Hackell,Ih Chang,Robert Kohberger,George R. Siber,Mathuram Santosham +13 more
TL;DR: PnCRM7 vaccine prevents vaccine serotype invasive pneumococcal disease even in a high risk population and other regions with similar disease burden should consider including this vaccine in the routine childhood vaccine schedule.
Journal ArticleDOI
Maternal influenza vaccination and effect on influenza virus infection in young infants.
Angelia A. Eick,Timothy M. Uyeki,Alexander Klimov,Henrietta Hall,Raymond Reid,Mathuram Santosham,Katherine L. O'Brien +6 more
TL;DR: Maternal influenza vaccination was significantly associated with reduced risk of influenza virus infection and hospitalization for an ILI up to 6 months of age and increased influenza antibody titers in infants through 2 to 3 months ofAge.
Journal ArticleDOI
Effect of Pneumococcal Conjugate Vaccine on Nasopharyngeal Colonization among Immunized and Unimmunized Children in a Community-Randomized Trial
Katherine L. O'Brien,Eugene V. Millar,Elizabeth R. Zell,Melinda A. Bronsdon,Robert Weatherholtz,Raymond Reid,Jocelyn Becenti,Sheri Kvamme,Cynthia G. Whitney,Mathuram Santosham +9 more
TL;DR: A community-randomized controlled trial investigating the effect of 7-valent PCV (PnCRM7) on NP colonization among American Indian infants and their unvaccinated contacts found it reduces the risk of VT acquisition and colonization density but increases therisk of NVT acquisition among vaccinees and their household contacts.
Journal ArticleDOI
Efficacy and safety of high-dose rhesus-human reassortant rotavirus vaccine in Native American populations
Mathuram Santosham,Lawrence H. Moulton,Raymond Reid,Janné Croll,Robert Weatherholt,Richard L. Ward,John Forro,Edward T. Zito,Michael E. Mack,George Brenneman,Bruce Davidson +10 more
TL;DR: Data indicate that RRV-TV is moderately efficacious in preventing all episodes of gastroenteritis caused by rotavirus and is most efficacious against the severe disease characteristic of rotaviral illness.